Sign inJoin waitlistJoin the waitlist

Janelle Perkins

Interim Assistant Dean, Faculty Affairs Professor, Department of Pharmacotherapeutics and Clinical Research · University of South Florida Morsani College of Medicine

Credentials: ·

History

Faculty Affairs Professor · University of South Florida Morsani College of Medicine
Present
University of South Florida Morsani College of Medicine
Present
University of South Florida Morsani College of Medicine
Present

Pharmacy, University of North Carolina
1986

Research

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone…
Journal of Clinical Oncology · 1996 · 161 citations
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation · 2010 · 116 citations
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis
Biology of Blood and Marrow Transplantation · 2010 · First of 13 authors · Corresponding · 93 citations

CA
Claudio Anasetti
27 papers
TF
Teresa Field
26 papers
Hugo Fernandez
22 papers
Mohamed Dabaja
22 papers
JP
Joseph Pidala
20 papers · 10 as a fellow
TN
Taiga Nishihori
19 papers
Ernesto Ayala
18 papers
LP
Lia Perez
18 papers
KF
Karen Fields
12 papers
MR
Marcie Riches
11 papers
MA
Melissa Alsina
10 papers
FL
Frederick Locke
8 papers

Clinical trials

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant
Principal investigator · Completed
H. Lee Moffitt Cancer Center and Research Institute
2008–2014
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
Principal investigator · Completed
H. Lee Moffitt Cancer Center and Research Institute
2005–2011
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
Principal investigator · Completed · Phase 4
H. Lee Moffitt Cancer Center and Research Institute
2005–2012